Why the study?
Does MRI at 1.5 Tesla accurately stage renal cell carcinoma compared to surgical findings in patients with surgically proven renal cell carcinomas?
Does MRI at 1.5 Tesla accurately stage renal cell carcinoma compared to surgical findings in patients with surgically proven renal cell carcinomas?
MRI at 1.5 Tesla is an accurate modality for preoperative staging of renal cell carcinoma, particularly useful for evaluating venous tumor extension without contrast.
Answers are grounded in this paper and cite their sources.
May support MRI for RCC venous staging; leaves open need for larger prospective validation before practice change.
The preoperative magnetic resonance imaging (MRI) studies of 31 patients with surgically proven renal cell carcinomas obtained with a 1.5 Tesla unit were retrospectively reviewed to assess the accuracy of MRI for staging of tumor. According to the Robson classification 12 patients were found at surgery to have Stage I renal carcinoma, three patients had Stage II, ten had Stage IIIA, one had Stage IIIB, two had Stage IIIC, one had Stage IVA, and two had Stage IVB disease. Twenty-five (81%) of 31 patients were staged correctly by MRI. Clearly MRI showed venous tumor extension without the need for intravenous contrast administration. Also, MRI had a negative predictive value of 95%, and a positive predictive value of 100% for the evaluation of inferior vena cava tumor thrombus. At 1.5 Tesla MRI is an excellent staging modality in the preoperative evaluation of renal carcinoma. It is especially recommended in patients with equivocal computed tomography findings and in all patients with contraindications to the intravenous use of iodinated contrast material.
No takes yet. Share an insight, caveat, or question.
Amendola et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: